Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.37 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.36 |
| ▸ | KDR | P35968 | 2/20 | 0.36 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.35 |
| ▸ | GSK3A | P49840 | 1/20 | 0.35 |
| ▸ | GSK3B | P49841 | 1/20 | 0.35 |
| ▸ | CSF1R | P07333 | 1/20 | 0.34 |
| ▸ | ALPL | P05186 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.31 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.30 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17628524 | 0.88 | LPL (0.40) | LPLLIPGPDGFRBKDRDGAT1 | |
| SCHEMBL32671782 | 0.88 | LPL (0.40) | LPLLIPGPDGFRBKDRDGAT1 | |
| SCHEMBL20109580 | 0.80 | LPL (0.45) | LPLLIPGCSF1REGFRPRMT5 | |
| SCHEMBL22155557 | 0.77 | LPL (0.43) | LPLLIPGCSF1REGFRPRMT5 | |
| SCHEMBL21066305 | 0.77 | LPL (0.45) | LPLLIPGCSF1RPRMT5WDR77 | |
| SCHEMBL19794332 | 0.75 | DGAT1 (0.48) | LPLLIPGPDGFRBKDRDGAT1 | |
| SCHEMBL18015442 | 0.74 | KDM4E (0.42) | LPLLIPGCSF1REGFRPRMT5 | |
| SCHEMBL20321608 | 0.72 | LPL (0.46) | LPLLIPGCSF1REGFRPRMT5 | |
| SCHEMBL2015694 | 0.72 | LPL (0.56) | LPLLIPGCSF1REGFRPRMT5 | |
| SCHEMBL15456760 | 0.72 | LPL (0.56) | LPLLIPGCSF1REGFRPRMT5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200235306-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2020-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200235306-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | OR10J3, PIEZO1, ODC1 | LPL 2133/4885LIPG 2787/4885PDGFRB 4863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.